Spots Global Cancer Trial Database for breast neoplasm
Every month we try and update this database with for breast neoplasm cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself. | NCT06086340 | Breast Cancer | Palbociclib Aromatase Inhib... | 65 Years - | Pfizer | |
| Cryoablation vs Lumpectomy in T1 Breast Cancers | NCT05505643 | Breast Cancer Breast Neoplasm | Endocare SlimLi... Lumpectomy | 50 Years - | Washington University School of Medicine | |
| A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer | NCT03024580 | Breast Neoplasm | Megestrol Aceta... Anastrozole 1Mg... Letrozole 2.5Mg... Exemestane 25 M... Tamoxifen 20Mg ... Fulvestrant 50M... | - | Instituto Nacional de Cancer, Brazil | |
| Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC) | NCT01231022 | Breast Neoplasm... Neoplasm Metast... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | ||
| CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | NCT04660929 | HER2-positive Adenocarcinoma Bile Duct Cance... Biliary Tract C... Bladder Cancer Breast Cancer Breast Neoplasm Carcinoma, Duct... Carcinoma, Hepa... Cancer Lung Cancer, No... Carcinoma, Ovar... Carcinoma, Smal... Carcinoma, Squa... Carcinoma, Tran... Colorectal Canc... Esophagogastric... Inflammatory Br... Stomach Neoplas... Malignant Neopl... Ovarian Neoplas... Pancreatic Canc... HER2-positive S... HER2-positive B... HER2-positive G... HER-2 Protein O... HER-2 Gene Ampl... Prostate Cancer Head and Neck C... Endometrial Can... Lung Cancer, Sm... | CT-0508 Pembrolizumab | 18 Years - | Carisma Therapeutics Inc | |
| Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast Cancer | NCT03269981 | Breast Neoplasm | Whole breast ir... Whole breast an... | 20 Years - 70 Years | Samsung Medical Center | |
| Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib | NCT02056080 | Breast Neoplasm | 18 Years - | MedSIR | ||
| Study for the Knowledge of Risk Factors Associated With Breast Cancer in Women | NCT03918668 | Breast Neoplasm... Nutrition Relat... Habits, Diet Cancer, Breast | Women with rece... | 18 Years - | Instituto de Investigación Hospital Universitario La Paz | |
| Effects of Raloxifene on the Uterus and Ovaries of Premenopausal Patients | NCT00001837 | Breast Cancer Breast Neoplasm | - | National Institutes of Health Clinical Center (CC) | ||
| Accelerated Hypofractionated Radiotherapy (AHF-RT) for the Treatment of Breast Cancer | NCT01278212 | Breast Cancer | accelerated hyp... | 21 Years - | University of Louisville | |
| Laser Optoacoustic and Ultrasonic Imaging System Assembly in Finding Changes in Tumors in Patients With Breast Cancer | NCT01755130 | Breast Neoplasm Inflammatory Br... | Photoacoustic I... | 20 Years - 85 Years | M.D. Anderson Cancer Center | |
| Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine) | NCT04341129 | Breast Neoplasm... Breast Diseases Breast Fibroade... Breast Cancer | Abbreviated MRI... | 18 Years - 80 Years | University of Chicago | |
| A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948) | NCT00779129 | Breast Neoplasm | Pegylated Lypos... Cyclophosphamid... | 18 Years - 75 Years | Merck Sharp & Dohme LLC | |
| Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors | NCT05364450 | Breast Neoplasm Breast Cancer Breast Carcinom... Malignant Neopl... Cancer of Breas... Mammary Neoplas... Human Mammary C... Malignant Tumor... Mammary Cancer Mammary Carcino... Anxiety Fear | Enhanced Usual ... Acceptance Comm... Cognitive Behav... | 18 Years - 99 Years | Indiana University | |
| Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia | NCT05050890 | Breast Neoplasm | ctDNA level dur... | 18 Years - | Instituto Brasileiro de Controle do Cancer | |
| Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer | NCT01061359 | Breast Neoplasm | Epirubicin: Obs... | - | Pfizer | |
| Development of Assist Tool for Breast Examination Using the Principle of Ultrasonic Sensor | NCT06255808 | Breast Cancer Breast Neoplasm Artificial Inte... Ultrasonography Benign Breast D... | 18 Years - 80 Years | Seoul National University Hospital | ||
| A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer | NCT06075810 | Breast Cancer Breast Neoplasm Breast Cancer S... | MBQ-167 | 21 Years - | MBQ Pharma | |
| Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer | NCT00005908 | Breast Cancer Breast Neoplasm | Docetaxel - Dos... Anastrozole cyclophosphamid... Docetaxel - Dos... Doxorubicin hyd... Tamoxifen Citra... Capecitabine - ... Capecitabine - ... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Study of ARV-471 (PF-07850327) Plus Palbociclib Versus Letrozole Plus Palbociclib in Participants With Estrogen Receptor Positive, Human Epidermal Growth Factor Negative Advanced Breast Cancer | NCT05909397 | Breast Cancer | ARV-471 (PF-078... Palbociclib Letrozole Palbociclib | 18 Years - | Pfizer | |
| Laser Fluorescence in Cancer Surgical Treatment | NCT03021200 | Esophageal Canc... Gastric Cancer ColoRectal Canc... Prostatic Neopl... Uterine Cancer Head and Neck C... Breast Neoplasm | Green indociani... | 18 Years - | Instituto do Cancer do Estado de São Paulo | |
| A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer | NCT03024580 | Breast Neoplasm | Megestrol Aceta... Anastrozole 1Mg... Letrozole 2.5Mg... Exemestane 25 M... Tamoxifen 20Mg ... Fulvestrant 50M... | - | Instituto Nacional de Cancer, Brazil | |
| Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer | NCT03688204 | Breast Cancer R... | 18 Years - | Ambry Genetics | ||
| Presentation of First Time Attenders at Lymphedema Clinics | NCT03687749 | Lymphedema Breast Neoplasm | 18 Years - | Universitaire Ziekenhuizen KU Leuven | ||
| Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors | NCT01204801 | Breast Cancer | Focused Microwa... Chemotherapy (c... | 18 Years - | Medifocus, Inc. | |
| Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine) | NCT04341129 | Breast Neoplasm... Breast Diseases Breast Fibroade... Breast Cancer | Abbreviated MRI... | 18 Years - 80 Years | University of Chicago | |
| Effectiveness of Ear Acupuncture to Improve Insomnia in Women With Breast Cancer | NCT03874598 | Breast Neoplasm | Ear acupuncture Psychoeducation | 18 Years - 75 Years | Universität Duisburg-Essen | |
| Evaluation of Real Imaging's 3D Functional Metabolic Imaging and Risk Assessment (MIRA) System | NCT02155075 | Breast Cancer | MIRA device ima... | 30 Years - | Real Imaging Ltd. | |
| Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED) | NCT00779285 | Breast Neoplasm | Pegylated Lipos... | 18 Years - | Merck Sharp & Dohme LLC | |
| Circulating Tumor Cells Screen for Breast Cancer | NCT05633680 | Breast Neoplasm Neoplastic Cell... | Peripheral bloo... | 18 Years - 85 Years | Handan First Hospital | |
| Yoga to Reduce Cancer Fatigue | NCT00583739 | Breast Neoplasm | Yoga | 18 Years - | University of Iowa | |
| Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy | NCT03220178 | Breast Neoplasm | Palbociclib Fulvestrant Anastrozole Letrozole Exemestane | 18 Years - | Palleos Healthcare GmbH | |
| PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition and/or Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Chemotherapy Resistant Residual Triple Negative Breast Cancer | NCT03740893 | Breast Neoplasm | AZD6738 Olaparib Durvalumab | 18 Years - | Institute of Cancer Research, United Kingdom | |
| Testing of the Cancer Thriving and Surviving Breast Cancer Program | NCT03651921 | Breast Neoplasm Early-Stage Bre... Self-Management Intervention Cancer Survivor... | CTS-BC-CH | 18 Years - | University of Lausanne | |
| A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer | NCT03024580 | Breast Neoplasm | Megestrol Aceta... Anastrozole 1Mg... Letrozole 2.5Mg... Exemestane 25 M... Tamoxifen 20Mg ... Fulvestrant 50M... | - | Instituto Nacional de Cancer, Brazil | |
| A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679) | NCT00687440 | Breast Neoplasm | Pegylated Lipos... Docetaxel Trastuzumab | 18 Years - 70 Years | Merck Sharp & Dohme LLC | |
| Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048) | NCT00550771 | Breast Neoplasm | doxorubicin, cy... PLD, cyclophosp... | 18 Years - | Merck Sharp & Dohme LLC | |
| Breast Cancer Screening With MRI in Women Aged 50-75 Years With Extremely Dense Breast Tissue: the DENSE Trial | NCT01315015 | Breast Cancer | Contrast enhanc... | 50 Years - 75 Years | UMC Utrecht | |
| Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment | NCT01596530 | Breast Neoplasm | Drug-AZD8931 Drug-Placebo | 18 Years - | AstraZeneca | |
| Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE® | NCT03445637 | Breast Neoplasm | 18 Years - | Pfizer | ||
| Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment | NCT02061085 | Breast Neoplasm Metastasis | Eribulina | 18 Years - | MedSIR | |
| Study for the Knowledge of Risk Factors Associated With Breast Cancer in Women | NCT03918668 | Breast Neoplasm... Nutrition Relat... Habits, Diet Cancer, Breast | Women with rece... | 18 Years - | Instituto de Investigación Hospital Universitario La Paz | |
| A Study of MLN8054 in Patients With Advanced Solid Tumors | NCT00249301 | Breast Neoplasm Colon Neoplasm Pancreatic Neop... Bladder Neoplas... | MLN8054 | 18 Years - | Millennium Pharmaceuticals, Inc. | |
| Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer | NCT00251095 | Breast Neoplasm | Taxol TOCOSOL Paclita... | 18 Years - | Achieve Life Sciences | |
| Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients | NCT00270894 | Breast Neoplasm | epirubicin cyclophosphamid... docetaxel trastuzumab | 18 Years - | Accelerated Community Oncology Research Network | |
| A Study of MLN8054 in Patients With Advanced Solid Tumors | NCT00249301 | Breast Neoplasm Colon Neoplasm Pancreatic Neop... Bladder Neoplas... | MLN8054 | 18 Years - | Millennium Pharmaceuticals, Inc. | |
| Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer | NCT03786575 | Breast Neoplasm... Therapeutics Mutation | Next Generation... | 18 Years - | Peking Union Medical College | |
| Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer | NCT05169567 | Breast Neoplasm Neoplasm Metast... | Abemaciclib Fulvestrant Placebo | 18 Years - | Eli Lilly and Company | |
| Prehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant Therapy | NCT06309290 | Prehabilitation Breast Cancer Postmenopause Resistance Trai... | Prehabilitation... Usual care prog... | - | Universidad de La Frontera | |
| Breast Edema Compression Vest | NCT02627976 | Edema Lymphedema Breast Neoplasm Breast Cancer | Compression ves... | 18 Years - | UMC Utrecht | |
| Complications After Lumpectomy, Sentinel Node and Radiotherapy in Breast Cancer Patients and Physiotherapy Care | NCT04444882 | Breast Neoplasm | - | University Hospital, Grenoble | ||
| Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer | NCT00623233 | Metastatic Brea... Locally Advance... | Gemcitabine Bevacizumab | 18 Years - | Eli Lilly and Company | |
| Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors | NCT05364450 | Breast Neoplasm Breast Cancer Breast Carcinom... Malignant Neopl... Cancer of Breas... Mammary Neoplas... Human Mammary C... Malignant Tumor... Mammary Cancer Mammary Carcino... Anxiety Fear | Enhanced Usual ... Acceptance Comm... Cognitive Behav... | 18 Years - 99 Years | Indiana University | |
| A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients | NCT05889988 | Breast Neoplasm | 18 Years - | Mayo Clinic | ||
| Anlotinib in Metastatic HER2 Negative Breast Cancer | NCT04002284 | Breast Neoplasm Antineoplastic ... Anlotinib | Anlotinib Hydro... | 18 Years - 75 Years | ChineseAMS | |
| Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 | NCT00034281 | Breast Neoplasm Pancreatic Neop... Lung Neoplasm Ovarian Neoplas... Renal Neoplasm | TAK-165 | 18 Years - | Takeda | |
| Virtual Exercise on Elderly Breast Cancer Survivors | NCT06432426 | Breast Cancer | Virtual reality... Standard physic... | 60 Years - 80 Years | Pontificia Universidad Catolica de Chile | |
| Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy | NCT06268665 | Breast Cancer Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Invasive Breast... Ovarian Cancer Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Ovarian Cancer ... Breast Cancer S... Breast Cancer I... Breast Cancer, ... Breast Cancer, ... Breast Cancer S... Breast Cancer S... Breast Cancer S... Breast Cancer S... Cancer, Breast Tumors, Breast Mammary Cancer Mammary Carcino... Breast Carcinom... Breast Neoplasm Malignant Breas... Malignant Tumor... Cancer of Ovary Ovary Cancer Ovary Neoplasm | Tart Cherry Jui... | 18 Years - | University of California, Davis | |
| Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy | NCT05665920 | Malignant Breas... | Ultra-hypofract... Standard Radiat... | 18 Years - | Instituto Brasileiro de Controle do Cancer | |
| A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679) | NCT00687440 | Breast Neoplasm | Pegylated Lipos... Docetaxel Trastuzumab | 18 Years - 70 Years | Merck Sharp & Dohme LLC | |
| Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer | NCT05020860 | Breast Cancer Breast Neoplasm Breast Cancer F... Breast Cancer I... Breast Cancer S... Breast Cancer S... Triple Negative... Hormone Recepto... HER2-positive B... Triple Negative... Estrogen Recept... | Paclitaxel Carboplatin Trastuzumab Pertuzumab Doxorubicin Cyclophosphamid... Pembrolizumab Pertuzumab/Tras... | 18 Years - | Baylor Breast Care Center | |
| Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 | NCT00034281 | Breast Neoplasm Pancreatic Neop... Lung Neoplasm Ovarian Neoplas... Renal Neoplasm | TAK-165 | 18 Years - | Takeda | |
| Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surgery | NCT03202472 | Breast Neoplasm Lesion | Implanted Medic... Mammography Questionnaire A... Radiofrequency ... Ultrasonography | 19 Years - | Jonsson Comprehensive Cancer Center | |
| Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC) | NCT01231022 | Breast Neoplasm... Neoplasm Metast... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | ||
| Cetuximab and Cisplatin in the Treatment of "Triple Negative" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer | NCT00463788 | Breast Neoplasm | cetuximab, cisp... cisplatin | 18 Years - | Merck KGaA, Darmstadt, Germany | |
| Breast Cancer: Feasibility of an Educational Intervention | NCT04396665 | Women's Health:... | Precam | 25 Years - 50 Years | University of Oviedo | |
| Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting | NCT03069742 | Breast Neoplasm | RealRisks BNAV | 35 Years - 75 Years | Columbia University | |
| A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer | NCT04699630 | Metastatic Brea... Locally Advance... | U3-1402 | 18 Years - | SCRI Development Innovations, LLC | |
| Radiotherapy for Extracranial Oligometastatic Breast Cancer | NCT04646564 | Breast Cancer M... | standard of car... radiotherapy + ... | 18 Years - 70 Years | ChineseAMS | |
| Ultrasonographic Axillary Localization | NCT04644848 | Breast Neoplasm | Ultrasonographi... Sentinel lymph ... Histopathologic... Further axillar... | 18 Years - | Mansoura University | |
| Cryoablation vs Lumpectomy in T1 Breast Cancers | NCT05505643 | Breast Cancer Breast Neoplasm | Endocare SlimLi... Lumpectomy | 50 Years - | Washington University School of Medicine | |
| Study for the Knowledge of Risk Factors Associated With Breast Cancer in Women | NCT03918668 | Breast Neoplasm... Nutrition Relat... Habits, Diet Cancer, Breast | Women with rece... | 18 Years - | Instituto de Investigación Hospital Universitario La Paz | |
| Evaluation of Real Imaging's 3D Functional Metabolic Imaging and Risk Assessment (MIRA) System | NCT02155075 | Breast Cancer | MIRA device ima... | 30 Years - | Real Imaging Ltd. | |
| GenetiKiT: Evaluation of an Educational Intervention on the Delivery of Genetics Services by Family Physicians | NCT00295529 | Breast Neoplasm | Multifaceted ed... | 20 Years - 80 Years | University of Toronto | |
| Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC) | NCT01231022 | Breast Neoplasm... Neoplasm Metast... | 18 Years - 70 Years | Peking University Cancer Hospital & Institute | ||
| Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer | NCT05169567 | Breast Neoplasm Neoplasm Metast... | Abemaciclib Fulvestrant Placebo | 18 Years - | Eli Lilly and Company | |
| Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery | NCT02372305 | Breast Neoplasm | FlexHD Alloderm | 18 Years - | University of Arkansas | |
| Post-treatment Care of Breast Cancer Survivors | NCT00821288 | Breast Neoplasm | Survivorship In... Facing Forward | 18 Years - | Columbia University | |
| Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary Treatment | NCT01859936 | Breast Neoplasm | MRI | 18 Years - 56 Years | Karolinska University Hospital | |
| Real-life Pan-HER-blockade With Neratinib | NCT04388384 | Breast Neoplasm | Neratinib | 18 Years - | Pierre Fabre Pharma GmbH |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
